Noveome Biotherapeutics, Inc. Completes $51 million Series E Financing to Support Clinical Trials in NEC

The financing will be primarily used to support the advancement of the Company’s clinical stage program for the treatment of Necrotizing Enterocolitis

PITTSBURGH, PA, UNITED STATES, April 23, 2025 /⁨EINPresswire.com⁩/ — Noveome Biotherapeutics, …